Roubaix Capital LLC bought a new position in IntriCon Co. (NASDAQ:IIN) in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 58,434 shares of the technology company’s stock, valued at approximately $1,466,000. Roubaix Capital LLC owned 0.67% of IntriCon as of its most recent SEC filing.
Several other institutional investors have also modified their holdings of IIN. Dimensional Fund Advisors LP boosted its holdings in shares of IntriCon by 11.0% in the 4th quarter. Dimensional Fund Advisors LP now owns 343,667 shares of the technology company’s stock worth $9,066,000 after acquiring an additional 34,031 shares in the last quarter. Millennium Management LLC boosted its holdings in shares of IntriCon by 30.7% in the 4th quarter. Millennium Management LLC now owns 33,425 shares of the technology company’s stock worth $882,000 after acquiring an additional 7,846 shares in the last quarter. Ranger Investment Management L.P. acquired a new position in shares of IntriCon in the 4th quarter worth approximately $2,676,000. Paloma Partners Management Co bought a new position in IntriCon in the 4th quarter worth approximately $264,000. Finally, Squarepoint Ops LLC raised its position in IntriCon by 37.3% in the 4th quarter. Squarepoint Ops LLC now owns 11,555 shares of the technology company’s stock worth $305,000 after purchasing an additional 3,138 shares during the last quarter. 64.83% of the stock is owned by institutional investors and hedge funds.
Shares of IntriCon stock opened at $26.67 on Thursday. The firm has a market cap of $229.72 million, a price-to-earnings ratio of 41.67, a price-to-earnings-growth ratio of 3.27 and a beta of 1.21. IntriCon Co. has a 52 week low of $20.95 and a 52 week high of $76.80.
In other IntriCon news, VP Greg Gruenhagen sold 1,500 shares of the company’s stock in a transaction on Monday, February 4th. The shares were sold at an average price of $26.21, for a total transaction of $39,315.00. Following the completion of the sale, the vice president now owns 4,049 shares in the company, valued at approximately $106,124.29. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders have sold a total of 7,500 shares of company stock valued at $198,225 in the last quarter. Corporate insiders own 11.50% of the company’s stock.
Several research firms recently weighed in on IIN. Zacks Investment Research upgraded shares of IntriCon from a “sell” rating to a “hold” rating in a research report on Wednesday. ValuEngine upgraded shares of IntriCon from a “hold” rating to a “buy” rating in a research report on Saturday, March 30th. Dougherty & Co upgraded shares of IntriCon from a “neutral” rating to a “buy” rating and set a $44.00 price objective for the company in a research report on Thursday, January 3rd. Finally, Stifel Nicolaus dropped their price objective on shares of IntriCon from $70.00 to $45.00 and set a “buy” rating for the company in a research report on Friday, January 4th. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. IntriCon has an average rating of “Buy” and an average target price of $50.25.
IntriCon Corporation, together with its subsidiaries, designs, develops, engineers, manufactures, and distributes body-worn devices in the United States, Europe, Asia, and internationally. The company operates in two segments, Body Worn Devices and Hearing Health Direct-To-Consumer. It offers micro-miniature products, microelectronics; micro-mechanical assemblies; high-precision injection-molded plastic components; and assemblies and software solutions for medical biotelemetry devices, hearing healthcare, and professional audio communication devices markets.
Featured Article: Put Option Volume
Receive News & Ratings for IntriCon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IntriCon and related companies with MarketBeat.com's FREE daily email newsletter.